Tae-Ho Hwang
Corporate Officer/Principal bei Pusan National University
Profil
Tae-Ho Hwang was the founder of SillaJen, Inc. which was founded in 2003, where he held the title of Chief Scientific Officer.
He currently holds positions as Director-Institutional Review Board at Pusan National University Hospital and Professor & Head-Biotherapeutic Research Center at Pusan National University.
Dr. Hwang's former positions include Member-Executive Board at SillaJen Biotherapeutics, Inc., Professor at Baylor College of Medicine, and Professor at Dong-A University.
Dr. Hwang received a doctorate degree from Pusan National University.
Aktive Positionen von Tae-Ho Hwang
| Unternehmen | Position | Beginn |
|---|---|---|
| Pusan National University | Corporate Officer/Principal | - |
Pusan National University Hospital
 Pusan National University Hospital Hospital/Nursing ManagementHealth Services Pusan National University Hospital operates as a university hospital. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Tae-Ho Hwang
| Unternehmen | Position | Ende |
|---|---|---|
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
| Baylor College of Medicine | Corporate Officer/Principal | - |
| Dong-A University | Corporate Officer/Principal | - |
| SILLAJEN, INC. | Gründer | - |
Ausbildung von Tae-Ho Hwang
| Pusan National University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SILLAJEN, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Commercial Services |
Pusan National University Hospital
Pusan National University Hospital Hospital/Nursing ManagementHealth Services Pusan National University Hospital operates as a university hospital. | Health Services |
